Cocrystal Pharma Inc reports results for the quarter ended in March - Earnings Summary

Cocrystal Pharma

16/05/2022 14:32

* Cocrystal Pharma Inc  COCP.OQ  reported a quarterly
adjusted
loss of 4 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 4 cents per share.
    * Reported revenue was zero​;  analysts expected $625.00
thousand. 
    * Cocrystal Pharma Inc's reported EPS for the quarter was a
loss
of 4 cents​.
    * The mean earnings estimate of analysts had risen by
about 12.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Cocrystal Pharma Inc shares had fallen by 26.2% this
quarter and
lost 37.6% so far this year.
    * The company reported a quarterly loss of $4.21 million.
    * Wall Street's median 12-month price target for Cocrystal
Pharma
Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 01:32 p.m.  ​All
figures in US dollars unless otherwise stated